In this episode of The Edventure Brief, the Edventure Co-Founders Ragnor Comerford and Fynn Comerford sit with Omri-Amirav Drory, Ph.D., general partner at NFX Bio. Following his Ph.D., he founded Genome Compiler, developing software for genetic engineers, molecular biologists and synthetic biologists, which was later acquired by Twist Bioscience. After heading Corporate Development at Twist, he founded Tech.Bio (https://www.tech.bio/), investing in and advising disruptive biotech companies such as Mammoth Biosciences, immunai, C2i Genomics, and many more.
We discuss his career path leading him from the lab bench to the VC table. We explore characteristics of successful founders in the biotech sphere and what it takes to succeed in this rapidly evolving industry as well as diving into the nuances of biotech and "techbio". We elaborate on questions regarding healthcare access, why drug development becomes more expensive and slow, and dabble a bit in topics such as longevity, immunology, and synthetic biology.
If you are working on some awesome biotech/techbio projects, do not hesitate to reach out to Omri here: omri@nfx.com
You can also check out his Linkedin profile here: https://www.linkedin.com/in/omri-amirav-drory-50572727/
Or find out more about NFX here: https://www.nfx.com/
About edventure: edventure is a community platform for students and researchers who seek to learn, solve problems, collaborate on projects, network, and build startups. Edventure's mission consists of leveraging entrepreneurship and innovation in science to tackle our planet's most pressing issues. We take a problem-led approach to building startups and provide a path to achieving the United Nations Sustainable Development Goals.
Visit our website: edventure.vc
Read some of our articles from The Edventure Blog: https://edventure.medium.com/
Follow us on Twitter: https://twitter.com/edventurevc
Follow us on LinkedIn: https://www.linkedin.com/company/edventure-capital
